From: "McLaren III, Jim A." <james.mclaren**At_Symbol_Here**TRINCOLL.EDU>
Subject: Re: [DCHAS-L] EPA Grants Manufacturer Request for Risk Evaluation of D4
Date: Wed, 7 Oct 2020 13:00:59 +0000
Reply-To: ACS Division of Chemical Health and Safety <DCHAS-L**At_Symbol_Here**Princeton.EDU>
Message-ID: MN2PR11MB39673633554C503CA0D0F507890A0**At_Symbol_Here**

Highlighted section came from Google search landing. Interestingly this quote comes from the Consumer Financial Protection Bureau.

So it appears that the EPA is trying to say the risk evaluation is complete from their point of view.

                                    Jim McLaren


(iv) Facially complete application. A loss mitigation application shall be considered facially complete when a borrower submits all the missing documents and information as stated in the notice required under paragraph (b)(2)(i)(B) of this section, when no additional information is requested in such notice, or once the servicer is required to provide the borrower a written notice pursuant to paragraph (c)(3)(i) of this section. If the servicer later discovers that additional information or corrections to a previously submitted document are required to complete the application, the servicer must promptly request the missing information or corrected documents and treat the application as complete for the purposes of paragraphs (f)(2) and (g) of this section until the borrower is given a reasonable opportunity to complete the application. If the borrower completes the application within this period, the application shall be considered complete as of the date it first became facially complete, for the purposes of paragraphs (d), (e), (f)(2), (g), and (h) of this section, and as of the date the application was actually complete for the purposes of this paragraph (c). A servicer that complies with this paragraph (c)(2)(iv) will be deemed to have fulfilled its obligation to provide an accurate notice under paragraph (b)(2)(i)(B) of this section.


From: ACS Division of Chemical Health and Safety <DCHAS-L**At_Symbol_Here**Princeton.EDU> On Behalf Of DCHAS Membership Chair
Sent: Wednesday, October 7, 2020 7:29 AM
To: DCHAS-L**At_Symbol_Here**Princeton.EDU
Subject: [DCHAS-L] EPA Grants Manufacturer Request for Risk Evaluation of D4


I'm not sure what "facially complete" means in the last paragraph below.


- Ralph


OPPT Update Header

EPA Grants Manufacturer Request for Risk Evaluation of D4

After reviewing the request and public comments, EPA is granting a manufacturer request for a risk evaluation of octamethylcyclotetra-siloxane (D4), a chemical used to make other silicone chemicals and as an ingredient in some personal care products. If the request is not withdrawn within 30 days, D4 will enter the Toxic Substances Control Act (TSCA) risk evaluation process.

Under TSCA, chemical manufacturers can request that EPA conduct a risk evaluation on a specific chemical. By giving manufacturers the opportunity to prioritize, identify, and request the evaluation of chemicals and conditions of use of interest to them, EPA is encouraging sensible and timely assessment of chemicals in the marketplace. Manufacturer-requested risk evaluations are conducted in the same manner as other TSCA risk evaluations.

Learn more about the D4 manufacturer-requested risk evaluation.


On March 19, 2020, EPA received a manufacturer request to conduct a risk evaluation of D4 from Dow Silicones Corporation, Elkem Silicones USA Corporation, Evonik Corporation, Momentive Performance Materials, Shin-Etsu Silicones of America, Inc., and Wacker Chemical Corporation through the American Chemistry Council's Silicones Environmental, Health, and Safety Center.

On April 8, 2020, EPA found this request to be facially complete. A 45-day public comment period was opened for this request on June 17, 2020, which allowed the public to submit comments relevant to the requested risk evaluation. 

Learn more about manufacturer-requested risk evaluations.


--- For more information about the DCHAS-L e-mail list, contact the Divisional membership chair at membership**At_Symbol_Here** Follow us on Twitter **At_Symbol_Here**acsdchas

Previous post   |  Top of Page   |   Next post

The content of this page reflects the personal opinion(s) of the author(s) only, not the American Chemical Society, ILPI, Safety Emporium, or any other party. Use of any information on this page is at the reader's own risk. Unauthorized reproduction of these materials is prohibited. Send questions/comments about the archive to
The maintenance and hosting of the DCHAS-L archive is provided through the generous support of Safety Emporium.